Fever-Associated Supraventricular Tachycardia after 4CMenB Vaccination in an Infant
Meningococcal serogroup B vaccine 4CMenB (Bexsero) is a new four-component protein vaccine developed to prevent Neisseria meningitidis serogroup B infections. Case. We report a girl with fever and supraventricular tachycardia (SVT) 6-8 hours after the second dose of 4CMenB. SVT was unresponsive to t...
Saved in:
Main Authors: | Erdem Gönüllü (Author), Burcu Topçu (Author), Naci Öner (Author), Ahmet Soysal (Author), Metin Karaböcüoğlu (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey
by: Erdem Gönüllü, et al.
Published: (2021) -
4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024) -
Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study
by: Ahmet Soysal, et al.
Published: (2021) -
Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020) -
Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021)